Immune homeostasis in the gut-associated lymphoid tissues (GALT) is critical to prevent the development of inadvertent pathologies. B cells, as the producers of antibodies and cytokines, play an important role in maintaining the GALT homeostasis. However, the mechanism by which B cells specifically direct their responses toward non-self-antigens and become ignorant to self-antigens in the GALT is not known. Therefore, we developed what we believe to be a novel mouse model by expressing duck egg lysozyme (DEL) in gut epithelial cells in presence of HEL-reactive B cells. Notably, we observed a transient activation and rapid deletion of self-reactive B cells in Peyer's patches and mesenteric lymph nodes upon self-antigen exposure. The survival of self-reactive B cells upon exposure to their self-antigen was partially rescued by blocking receptor editing but could be completely rescued by stronger survival signal, such as ectopic expression of BCL2. Importantly, rescuing the self-reactive B cells promoted production of autoantibodies and gut inflammation. Mechanistically, we identify a specific activation of TGF-b signaling in selfreactive B cells in the gut and a critical role of this pathway in maintaining peripheral tolerance. Collectively, our studies describe functional consequences and the fate of selfreactive B cells in GALT and provide potentially novel mechanistic insights governing selftolerance of B cells in the gut.
Introduction
The mammalian intestine is a complex environment that is continuously exposed to vast variety of antigens from commensal and pathogenic microbes as well as dietary factors (1) (2) (3) . These antigens pose a unique challenge for the innate and adaptive immune system to discriminate between harmful versus innocuous antigens to restrain the spread of pathogenic microbes, while also avoiding aberrant inflammatory encounters (4, 5) . Immune cells are positioned in the subepithelial layers where they constantly surveil for invading harmful pathogens. The immune system is an integral part of the gut tissue that is required for maintaining its homeostasis. The protective mucus layers, along with the secreted Igs, particularly IgA, represent critical checkpoints to prevent the entry and spread of pathogenic microbes (6) (7) (8) (9) . However, under certain pathological conditions, the unrestrained activation of immune responses due to a breach in the mucosal barrier leads to several autoimmune pathologies and perturbation of normal gut homeostasis (2, 10) .
B cells are an intricate part gut immunity and also play a pivotal role in the maintenance of intestinal tissue. In the event of a breach in the epithelial barrier, B cells can respond to gut pathogens to prevent dissemination and ultimately resolve infection (11) (12) (13) (14) . B cells perform these functions by producing Igs as well as several immune modulatory cytokines (12) (13) (14) (15) . The Igs secreted by plasma cells are captured by poly-Ig receptors on the basolateral surface of the epithelia to mediate endocytosis of Ig complexes that can be cleaved and transported into the apical lumen via transcytosis where they serve to neutralize the foreign microbes. The Ig-antigen complexes also function to deliver antigens into the subepithelia for presentation to other immune cell subsets (7) . Moreover, B cells in the gut are potent producers of immunomodulatory cytokines, such as IL-10, that have pleiotropic effects (16) . These immunomodulatory cytokines are important for maintaining the immune homeostasis in the gut-associated lymphoid tissues (GALT), blunting excessive inflammatory responses, and regulating the balance between commensal and pathogenic microbes (14) (15) (16) (17) . Although, B cells are known to be important for maintaining gut homeostasis, the regulation of B cell responses in the gut is incompletely understood.
Immune homeostasis in the gut-associated lymphoid tissues (GALT) is critical to prevent the development of inadvertent pathologies. B cells, as the producers of antibodies and cytokines, play an important role in maintaining the GALT homeostasis. However, the mechanism by which B cells specifically direct their responses toward non-self-antigens and become ignorant to self-antigens in the GALT is not known. Therefore, we developed what we believe to be a novel mouse model by expressing duck egg lysozyme (DEL) in gut epithelial cells in presence of HEL-reactive B cells. Notably, we observed a transient activation and rapid deletion of self-reactive B cells in Peyer's patches and mesenteric lymph nodes upon self-antigen exposure. The survival of self-reactive B cells upon exposure to their self-antigen was partially rescued by blocking receptor editing but could be completely rescued by stronger survival signal, such as ectopic expression of BCL2. Importantly, rescuing the self-reactive B cells promoted production of autoantibodies and gut inflammation. Mechanistically, we identify a specific activation of TGF-β signaling in self-reactive B cells in the gut and a critical role of this pathway in maintaining peripheral tolerance. Collectively, our studies describe functional consequences and the fate of self-reactive B cells in GALT and provide potentially novel mechanistic insights governing self-tolerance of B cells in the gut. B cell tolerance mechanisms, which include clonal deletion, receptor editing, and anergy, have been well investigated with regard to selection of newly formed B cells in bone marrow (18, 19) . However, the tolerance mechanisms that limit self-reactivity to self-antigens expressed in peripheral tissues is less clear. We have previously shown that, in the context of an autoantigen expressed on follicular dendritic cells in the spleen, self-reactive B cells are rapidly eliminated at the transitional B cell developmental stage to limit self-reactivity (20) . Whether similar mechanisms operate in much more convoluted peripheral tissue, such as the GALT, is not well studied. In GALT, discrimination of antigens from pathogenic bacteria, beneficial bacteria, food, and self-antigen by B cells is vital. Furthermore, in anatomical sites, such as Peyer's patches (PPs) and isolated lymphoid follicles, B cells are eliciting an immune response toward pathogenic antigens. The high degree of immune cell activation makes gut predispose to autoimmunity. How B cells make this distinction between self versus non-self at this site is not known. Interestingly, B cells have been shown to express RAG proteins and undergo Ig rearrangements in the lamina propria but not the PPs during neonatal development in the mouse, an event that coincides with establishment of the microbiota (21) . These observations suggest that B cell tolerance appears to occur in the gut, where B cells may undergo secondary rearrangements to execute receptor editing and evade reactivity to putative self-antigens. Besides, the level of autoantibodies is often elevated in patients with inflamed gut, and it is unclear of whether self-reactive B cells initiate the disease or they get recruited at the site upon tissue destruction. Therefore, we wanted to investigate if specific mechanisms exist to render B cells tolerant to self-antigen in the gut.
In our studies, we developed what we believe to be a novel mouse model to study B cell tolerance against the duck egg lysozyme (DEL) as a neo-self-antigen expressed on gut epithelial cells. Strikingly, we observed that the self-reactive B cells are transiently activated in response to self-antigen before being rapidly eliminated in the PPs and the draining mesenteric lymph nodes (mLNs). The elimination of self-reactive B cells could be rescued by blocking receptor editing or by strong survival signaling, such as an ectopic overexpression of BCL2, but not by cell-extrinsic survival signals, such as excessive BAFF. Notably, the rescue of self-reactive B cell survival by expression of BCL2 lead to the production of autoantibodies to HEL, which ultimately progressed to the inflammation in gut and autoantibody production. Transcriptomic analysis revealed specific activation of the TGF-β signaling pathway in self-reactive B cells in the GALT, and inhibition of this pathway altered the fate of self-reactive B cells in the gut and rescued their survival. To our knowledge, this is the first model to study B cell tolerance in the GALT. In our model, mature self-reactive B cells get eliminated in the gut; however, the pool in tissues such as spleen remains unaltered. Our work defines how B cell tolerance mechanisms operate in the gut to limit self-reactivity and provide mechanistic insights into the molecular pathways regulating these events.
Results
Self-reactive B cells are eliminated upon antigen encounter in the gut. B cells in gut GALT are constantly exposed to a range of potential antigens; however, the B cell immune responses are kept in check by the induction of peripheral tolerance at steady state. How the peripheral tolerance in gut is induced and maintained remains poorly understood. To gain insights into this process, we generated a model by crossing transgenic mice expressing membrane-bound DEL (mDEL) with mice carrying Villin-Cre to obtain Villin cre mDEL loxp mice. In these mice, upon Cre-mediated recombination, mDEL was expressed uniformly and exclusively throughout the gut epithelial cells, including M cells. DEL displayed a much lower affinity (~3500-fold, 1.3 × 10 7 per M) for the HEL-specific B cell receptors (BCR), which are often used as a model to study central and peripheral tolerance, compared with an extraordinarily high affinity exhibited by HEL (4.5 × 10 10 per M), which perhaps makes DEL a more physiological model to study tolerance (22, 23) . To study the induction of B cell tolerance, we further bred the Villin cre mDEL loxp mice with the SW HEL knockin mice that generate self-reactive HEL-specific B cells ( Figure 1A) . B cells from SW HEL mice expressed the same rearranged BCR allele as those in the MD4 HEL-transgenic mice, with the exception that the rearranged HEL-specific allele in SW HEL mice was targeted into the IgH locus. 10%-25% of peripheral B cells in adult SW HEL mice display specificity to HEL and undergo receptor editing, normal isotype switching, as well as somatic hypermutation (24) .
We first examined whether the expression of DEL in gut epithelia indirectly affects the gut microbiome. Fecal samples were collected from mice with several different genotypes, including those from the Villin cre+ mDEL loxp SW HEL mice and Villin cre+ SW HEL mice not expressing DEL (Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.130621DS1).
Additionally, fecal samples were also obtained from wild-type mice following administration of HEL via oral gavage at multiple time points. Bacterial genomic DNA was purified from different samples and deep sequenced for the V4 region of the 16S rRNA gene to measure the diversity of bacterial phyla. The microbial diversity was mostly unaffected by the presence of DEL as a membrane fusion protein or by acute oral administration of HEL (Supplemental Figure 1B) . This clearly indicated that perturbation of the gut microbiome is not a cell-extrinsic obfuscating factor of B cell tolerance to DEL as a specific autoantigen in our model. Figure 2B ). The replenishment of newly formed cells was not observed in non-HEL-specific cells ( Figure 2C ). These data could be reconciled in two possible ways: either HEL-specific B cells transiently proliferate upon encountering present cognate antigen in GALT or they are constantly replenished by BrdU-labeled cells from the bone marrow. To test the first scenario, we isolated and labeled splenic B cells from SW HEL mice with efluoro670 dye to track their proliferation. (E) B cell percentages in spleens, pLNs, mLNs, and PPs and HEL-specific cell percentages in spleens, pLNs, mLNs, and PPs and absolute numbers of HEL-specific B cells in PPs isolated from RVillin cre+ and RVillin cre+ mDEL loxp mice after 8 weeks after reconstitution. Data are representative of 3 mice per group; the experiment was repeated more than 3 times; and data were analyzed using 2-way ANOVA and grouped multiple t test. ****P < 0.0001, **P < 0.005, *** P < 0.001, * P < 0.05. of its cognate antigen. Therefore, we next analyzed whether HEL-specific B cells display features of cellular activation upon antigen encounter. BCR, upon binding to its antigen, is internalized, and, as a consequence, the cell surface levels of BCR are downregulated. We compared the cell surface levels of HEL-binding BCR of HEL-specific self-reactive B cells upon antigen encounter in RVillin
Cre mDEL loxP mice. An approximately 2-and 1.5-fold reduction in the MFI of surface Ig and HEL-specific BCR were observed in mLNs and PPs of RVillin Cre mDEL loxP mice compared with HEL-specific B cells from RVillin Cre mice ( Figure 3 , A, B, and E). Moreover, the levels of cell surface Ig and HEL-specific BCR were comparable at lymphoid tissues not expressing the antigen, such as pLNs and spleens. We also evaluated the expression of B cell activation markers, CD69 and CD86, on HEL-specific B cells in the + HEL + cells in spleens, pLNs, mLNs, and PPs of 5 mice per group. Grouped statistical analysis was performed by multiple t test. ****P < 0.0001, **P < 0.005, ***P < 0.001, *P < 0.05. presence or absence of its antigen. We observed an increase in the levels of CD69 and CD86 in PPs and mLNs of RVillin Cre mDEL loxP mice compared with RVillin Cre mice ( Figure 3 , C and D). Interestingly, the upregulation of CD69, which is considered an early marker of cell activation, was much more pronounced on HEL-specific B cells in the PPs, while CD86, an activation marker with costimulatory functions, was significantly upregulated in mLNs. These data indicate that HEL-specific B cells, upon encountering the self-antigen at the gut epithelia, are transiently activated and a subset among these cells traffic to the mLN, where they undergo further activation. Even though the HEL-specific B cells underwent activation, they failed to enter the germinal center reaction, as indicated by the lack of germinal center B marker, GL7 (Figure 3, F and G) . Together, these data show that HEL-specific B cells undergo activation upon antigen encounter in the GALT.
Self-reactive B cells undergo deletion and receptor editing in the GALT. Our results showed that HEL-specific B cells, upon binding to self-antigen in GALT, undergo cellular activation, and their numbers undergo reduction. This suggests that upon antigen encounter the majority of HEL-specific B cells in GALT are clonally deleted or are shunted toward a terminal differentiation pathway, leading to the generation of short-lived plasma cells. To address these scenarios, we first monitored the production of autoantibodies specific to HEL by using a flow-based assay developed in our laboratory (25) . Serum and fecal extracts were collected from RVillin Cre+ mDEL loxP and control RVillin Cre+ mice, and then the antibody titers were measured. We did not observe any significant differences in the production of HEL-specific antibodies of IgM, IgG1, and IgA isotypes in the sera and fecal extracts (Supplemental Figure 3, A and B ). These results demonstrate that HEL-specific B cells upon antigen encounter are not channeled toward a terminal plasma cell differentiation pathway.
We then investigated the possibility for clonal elimination of HEL-specific B cells upon encountering self-antigen in GALT. We analyzed several markers associated with cell death on HEL-specific cells from RVillin Figure 4B) ; however, the architecture of follicles was retained (Supplemental Figure 4F ). These results indicate that self-reactive B cells undergo elimination upon encountering its antigen. To test whether the provision of an external survival signal would prevent the elimination of self-reactive B cells in GALT, we used a human CD68 promoter-driven BAFF-transgenic mouse line and crossed it to SW HEL mice (SW HEL Baff) (26) . BAFF belongs to the TNF superfamily of receptors and is a well-known survival factor for mature B cells in the periphery. The RVillin . This was particularly intriguing, as higher levels of BAFF have been associated with autoimmune diseases, including ulcerative colitis and Crohn's disease, and BAFF-transgenic mice have also been shown to develop autoimmunity (26) (27) (28) . However, in our experimental system, overexpression of BAFF alone was not sufficient to breach tolerance against a gut-associated self-antigen.
SW HEL B cells undergo V H replacement of the knockin allele, which is the primary reason that only 20%-30% of the peripheral B cells are HEL specific. Therefore, to determine the maximal efficiency of negative selection in the absence of secondary recombination events, we crossed the SW HEL mice onto a Rag2-null background to obtain SW HEL (Rag2 KO ) mice. In this case, all peripheral B cells bind HEL and allow us to evaluate receptor downmodulation and apoptosis in straightforward manner relative to control mice lacking mDEL expression. Next, we reconstituted Villin cells. ***P < 0.001, **P < 0.01, ****P < 0.0001, *P < 0.05; n = 9 mice per group. Grouped statistical analysis was performed by multiple t test.
PPs of RVillin
Cre mDEL loxP (Bcl2) mice compared with the RVillin Cre (Bcl2) control mice ( Figure 6A ). Second, to determine if the fate of these self-reactive B cells is altered, we measured the BCR-specific antibody production in serum and fecal extracts. Interestingly, we observed a significant (~1.5 fold) increase in HEL-specific IgA antibody in the serum and fecal extracts, whereas a nonsignificant increase in HEL-specific IgG1 antibody was observed in sera of RVillin These included submucosa and mucosa infiltration by lymphocytes, flattening of crypts, and, in general, a higher degree of inflammation ( Figure 6, C-E) . Notably, these pathologies developed spontaneously, displaying higher pathological scores, and the other 2 mice (no. 922 and no. 500) showed milder but overt signs of pathologies (Table 1) . Importantly, none of the RVillin Cre mDEL loxP (Bcl2) control mice from the same cohort developed such conditions. Together, these observations suggest that intrinsic survival signals such as those provided by ectopic expression of Bcl2 cause a breach in peripheral tolerance in the gut, leading to development of overt inflammatory pathologies.
Transcriptional profiling of HEL-specific self-reactive B cells reveals upregulation of TGF-β signaling.
To elucidate the molecular mechanism involved in rendering B cells tolerant to the self-antigen at the GALT, we performed transcriptional profiling. To do so, HEL-specific and non-HEL-specific B cells were sorted from spleens, mLNs, and PPs from 3 different Villin cre+ mDEL loxp SW HEL mice and then RNA-Seq was performed. The HEL-specific B cells from spleens were used as controls to demarcate the transcriptional profile in the absence of self-antigen encounter, and non-HEL-specific B cells from the spleen, mLNs, and PPs served as internal controls for defining tissue-specific gene signatures. We first performed hierarchical clustering analysis to identify the relative similarity between the transcriptional profiles of different samples Figure 7A . As expected, the HEL-specific self-reactive B cells, particularly those from the PPs and mLNs, clustered together; while the non-HEL-specific non-self-reactive B cells from mLNs and spleens as well as HEL-specific B cells from the spleens appeared more closely related to one another. The non-HEL-specific B cells in PPs showed some resemblance to HEL-specific B cells in PPs, likely because a subset among these cells undertakes a germinal center program and displays features of cell activation.
We then compared these data sets in various permutations to first identify differentially expressed gene (DEG) signatures in HEL-specific cells in PPs versus those present in mLNs and spleens. Our analysis identified 591 and 488 DEGs in HEL-specific cells in PPs compared with mLNs and spleen, respectively Figure 7B . Concurrently, we identified 926 and 862 DEGs in non-HEL-specific cells in PPs compared with mLNs and spleens (Supplemental Figure 4) . We further used the HEL-specific and non-HEL-specific DEG signatures to perform MetaCore and Metascape pathway analysis, which revealed a total of 10 statistically significant unique molecular pathways differentially regulated among self-reactive HEL-specific B cells upon self-antigen exposure in PPs compared with mLN and spleens ( Figure 7C ). Similarly, a total of 16 differentially regulated molecular pathways were identified among non-HEL-specific B cells in PPs compared with mLNs and spleens, and these were used to determine tissue-specific changes ( Figure 7D ). These uniquely regulated pathways in HEL-specific and non-HEL-specific B cells at PPs were then compared with each other to delineate 8 unique molecular pathways that are specifically enriched among HEL-specific B cells upon self-antigen exposure ( Figure 7E) . Notably, among these pathways, our analysis revealed a significant enrichment of a TGF-β signaling-induced network in HEL-specific cells in PPs. To investigate this further, we performed a Gene Set Enrichment Analysis using a panel of TGF-β signature genes (identified by treatment of T cells with TGF-β in culture) to test for the enrichment of TGF-β signaling activity in HEL-specific B cells in PPs. Remarkably, we obtained a robust and significant enrichment of TGF-β signature genes among DEGs in HEL-specific B cells in PPs when compared with HEL-specific B cells in spleens ( Figure 8A ). Moreover, we also observed a trend among DEGs identified upon comparison between HEL-specific and non-HEL-specific B cells at PPs for enrichment of TGF-β signature genes ( Figure 8B ). Furthermore, we observed the enrichment of TGF-β signature genes in HEL-specific cells from PPs from Villin Figure 8C ). Collectively, using systematic and stringent analysis criteria, our studies revealed specific upregulation of the TGF-β signaling pathway in HEL-specific B cells following exposure to self-antigen in GALT.
We also performed transcriptional profiling of HEL-specific B cells isolated from PPs, mLNs, and spleens of RVillin Cre mDEL loxP (Bcl2) mice to identify molecular pathways that are deregulated upon breaching of B cell tolerance in the gut. As described above, we identified DEGs in HEL-specific B cells from PPs H&E staining of the duodenum, small intestine, large intestine, and colon was performed. Slides were scored blinded based on the criteria described. Six mice in the RVillin cre+ (Bcl2) control group and seven mice in the RVillin cre+ mDEL loxp (Bcl2) experimental group were scored. compared with those in mLNs and spleens. Our analysis revealed a total of 232 genes upregulated and 138 genes downregulated in HEL-specific B cells in the PPs compared with spleens, and these were used to perform MetaCore pathway analysis. Once again, we observed activation of the TGF-β signaling pathway in PP HEL-specific B cells (Supplemental Figure 5) , implying that Bcl2 rescues the survival of self-reactive Figure 9A ). This was in line with our previous finding in Figure 6A that HEL-specific cells in RVillin Cre mDEL loxP (Bcl2) mice have a survival advantage and switch to IgA. We next tested whether inhibition of TGF-β signaling could rescue the survival of self-reactive HEL-specific cells in GALT. For these studies, we took a pharmacological approach and used a TGFβR1/2-specific inhibitor, LY2109761, to inhibit TGF-β signaling. We isolated splenic B cells from SW HEL mice that constituted a mixture of HEL-specific and non-HEL-specific B cells and cultured them in the presence of TGFβR1/2 inhibitor or DMSO for 2 hours. After 2 hours, we washed and labeled the TGFβR1/2 inhibitor-or DMSO-treated cells with cell trace dyes, CFSE, and Efluor670 or CTV dye, respectively ( Figure 9B and Supplemental Figure 7) . The TGFβR1/2 inhibitor-or DMSO-treated and differentially labeled cells were then mixed together and intravenously injected into Villin cre+ mDEL loxp mice. Mice were analyzed 72 hours after injections for relative proportions of transferred cells in spleens, mLNs, pLNs, and PPs. Interestingly, we observed significantly higher frequencies of HEL-specific B cells treated with TGFβR1/2 inhibitor compared with DMSO-treated HEL-specific cells within the spleens, mLNs, pLNs, and PPs of the same mice ( Figure 9B ). Importantly, the frequencies of non-HEL-specific B cells treated with TGFβR1/2 inhibitor were unaltered when compared with non-HEL-specific B cells treated with DMSO ( Figure 9B ). To ratify the activity of drug at 72 hours after injection we measured p-smad2/3 levels and observed significant, approximately 1.5-to 10-fold, downregulation in TGFβR1/2 inhibitor-treated HEL-specific cells from spleens, mLNs, and PPs ( Figure 9C ). The TGFβR1/2 inhibitor-treated HEL-specific cells compared with DMSO-treated cells showed upregulation of CD69, an activation gene known to be suppressed by TGF-β signaling (32) , and showed higher levels of the cell migration marker, S1PR1, indicating less B cell retention in gut ( Figure 9D ). Overall, we observed an increase in frequencies of HEL-specific B cells, not just in PPs and mLNs, but also in pLNs and spleens, suggesting that, once rescued, the HEL-specific B cells readily recirculate through secondary lymphoid tissues. Together, our results here demonstrate that inhibition of TGF-β signaling in a B cell-intrinsic manner rescues the survival of self-reactive B cells in the GALT, demonstrating a critical role for TGF-β signaling in regulating B cell tolerance at GALT.
Discussion
The GALT is a complex microenvironment, in which B cells are challenged by a vast variety of harmless and pathogenic antigens. Our understanding of how B cells discriminate between these different antigens to either become ignorant or generate functional immune responses is quite limited. In our studies here, we developed a potentially novel mouse model to study the interaction of self-reactive B cells with cognate autoantigen in the gut. Our model mimics physiological scenarios, where only a small fraction (10%-20%) of B cells harboring self-reactive BCR develop in the bone marrow and egress into the periphery. Notably, our studies unraveled robust tolerance mechanisms that rapidly abolished self-reactive B cells in the gut to suppress the development of overt pathologies. Delivery of cell-intrinsic survival signal by ectopic expression of Bcl2 rescued the terminal fate of autoreactive B cells and caused inflammation in gut. We performed transcriptomics analysis and used stringently curated filtering criteria to identified specific activation of TGF-β signaling in self-reactive -HEL-specific B cells that contributed to the elimination of self-reactive B cells in the gut. In our studies here we observed the induction of tolerance to an autoantigen that is expressed on the cell surface of intestinal epithelial cells. It will be interesting to investigate whether similar mechanisms exist to induce tolerance against cross-reactive self-antigens from commensal microbiota and dietary factors in gut. mice from intestinal immune network for IgA production (P < 0.05). n = 3 HEL-specific samples, n = 2 for non-HEL-specific samples, and n = 3 for RVillin cre+ mDEL loxp (Bcl2).
Our studies reveal that similar to receptor editing and clonal deletion of self-reactive B cells during central tolerance induced in bone marrow, the self-reactive B cells in the gut undergo BCR rearrangement and apoptosis following encounter with its autoantigen. Therefore, the induction of receptor editing and apoptosis represents the major mechanism contributing to peripheral tolerance in the gut. Our studies identify PPs as the primary inductive site where B cells are rapidly eliminated. However, how the self-reactive BCR receives, relays, and delivers an apoptotic or BCR rearrangement signal upon autoantigen encounter in the gut remains unclear. Perhaps, the specific cytokine milieu in the PPs contributes to this outcome, in which BCR engagement with an autoantigen without relevant T cell help Graph of HEL-specific cells treated with DMSO or TGFβI/II R inhibitor in spleens, pLNs, mLNs, and PPs (D) of CD69 MFI and S1PR1 MFI. The statistical analysis was done by paired t test in Prism. ****P < 0.0001, ***P = 0.0002, **P = 0.0077, *P = 0.0105, n = 4 and experiment was repeated 3 times.
translates to propagation of a death signal in self-reactive B cells. Yet, the signal that directs BCR rearrangement in the gut is still not understood.
Mechanistically, our studies identify activation of the TGF-β signaling pathway in HEL-specific self-reactive B cells in the gut leading to their rapid elimination. Pharmacological inhibition of TGF-β signaling by using an inhibitor specific to TGFβR1/R2 reversed these phenotypes, promoted the survival of self-reactive B cells in the gut, and led to expression of chemokines that allowed homing of self-reactive B cells to other peripheral tissues. The TGF-β signaling pathway is shown to have pleiotropic effects on B cells (33) (34) (35) (36) (37) (38) (39) (40) . In mucosal tissues, TGF-β signaling is known to be crucial for IgA production, where it cooperates with CD40 ligand and other cytokine signals delivered by T cells to induce class switch recombination in B cells (37) . In human B cells lines (and also in mouse B cells), TGF-β signaling induces apoptosis by repressing the expression of the antiapoptotic protein BCL-XL and by directly inducing the expression of the proapoptotic protein PUMA (39, 40) . TGF-β signalinginduced apoptosis in B cells is shown to occur in an autocrine manner (35, 36) , and PP B cells are known to produce significant amounts of TGF-β (33) . Whether and how TGF-β signaling functions in an autocrine manner in self-reactive HEL-specific B cells to deliver a proapoptotic signal still remains unclear. It is worth pointing out that we observed higher mRNA expression of TGFβR1 and TGFβR2 in self-reactive HEL-specific B cells in PPs compared with non-HEL-specific B cells (Supplemental Figure 6 ). However, due to lack of appropriate reagents, we were not able to test the changes in protein expression of TGFβR1 and TGFβR2. Perhaps the higher levels of TGFβR1 and TGFβR2 make self-reactive HEL-specific B cells more sensitive and responsive to TGF-β levels in PPs. Interestingly, a recent study showed that activation of TGF-β signaling in PP B cells leads to upregulation of the latent TGF-β-binding protein, GARP (41) , which can induce production of active TGF-β from latent TGF-β in human B cells to boost IgA production (42) . Even though, we did not observe any significant differences in the expression of Lrrc32, the gene encoding GARP, in self-reactive B cells compared with non-self-reactive B cells in PP, it is reasonable to speculate that higher expression of GARP in PP B cells may contribute to higher levels of active TGF-β in the PP tissue microenvironment, which may act in a paracrine axis to induce tolerance. Consistent with this notion, GARP was shown to function in a B cell-specific manner to regulate the induction of peripheral tolerance in a model of oral sensitization (41) . Taken together, our studies presented here highlight TGF-β signaling as a critical checkpoint for induction of peripheral tolerance in self-reactive B cells in the gut. In line with our findings, extrinsic influences, such as excessive BAFF-producing macrophages, do not rescue or alter the fate of the self-reactive B cells. However, provision of a stronger prosurvival signal, such as BCL2, in RVillin Cre mDEL wt (Bcl2) mice, completely rescues self-reactive cells. In addition to the activation status being retained, the TGF-β signaling pathway was also enriched in HEL-specific cells in PPs. Further, the percentage of BIM + self-reactive B cells was still significantly high, indicating that BCL2 only rescues the phenotype but does not alter BCR signaling downstream. Moreover, an interesting finding of this study is that just upon receiving survival signaling these cells switched to IgA and an increase in HEL-specific IgA antibody was observed.
Our studies here demonstrate that B cell-intrinsic activation of TGF-β signaling is important for induction of peripheral tolerance in self-reactive B cells. It is important to point out that we did not observe T cell-mediated immune responses directed toward mDEL, indicating that mDEL is truly perceived as "self " in our model. These observations also suggest mechanisms of tolerance that involve diverse immune cell subsets. Previous studies have shown important functions of tolerogenic subsets of dendritic cells and T regulatory cells in actively controlling immune responses to self-and commensal-antigens in gut (43, 44) . It would be interesting to further investigate the possible interplay between tolerogenic immune cell subsets and induction of B cell tolerance in the GALT. Importantly, a B cell-intrinsic breach in tolerance by Bcl2 expression in our model was sufficient to induce an inflammatory phenotype and development of pathologies, indicating that B cells play a prominent role in regulating tolerance to self-antigen(s) in the gut.
We show that ectopic expression of BCL2 rescued the survival of self-reactive B cells. Interestingly, the transcriptomic profiling of BCL2-overexpressing HEL-specific B cells still showed activation of the TGF-β signaling pathway, suggesting that B cell-intrinsic survival signal does not alter the upstream events that lead to induction of TGF-β signaling in self-reactive B cells. Importantly, our results clearly show that breach in tolerance induction by forced expression of BCL2 in B cells triggered a cascade of events that promotes activation of an inflammatory immune signature. These findings strongly suggest that B cells have important immunoregulatory functions in mucosal tissues. Consistent with our findings, absence of B cells in mice causes alterations in the cytokine milieu of GALT (17) , and rituximab (B cell-depleting antibody) treatment in humans has been linked to development of colitis (45) . In our studies, breakdown of B cell-intrinsic tolerance mechanisms by BCL2 expression caused development of overt inflammation with many of the clinical symptoms commonly associated with diseases such as autoimmune enteropathy and celiac disease in humans. This to our knowledge is the first model to study B cell tolerance to gut-associated self-antigens.
In summary, we generated and used a potentially novel mouse model to interrogate B cell-specific responses to their cognate autoantigen in gut. We performed a systematic analysis to show that B cell responses to an autoantigen are actively curtailed by cell-intrinsic tolerance mechanisms in gut and any breach in this process leads to development of pathologies. We further provide what we believe to be novel insights into the molecular mechanisms that control the induction of peripheral tolerance and identify the TGF-β signaling pathway as a critical checkpoint for regulating this process.
Data analysis. All flow cytometry data were collected with BD FACSDiva and analyzed using FlowJo Version 8.8.7.
Intestinal epithelial cell isolation. The intestine was removed and transferred into cold PBS. Intestinal contents were removed, and the intestine was cut open longitudinally and washed in cold PBS. The tissue was then placed into a tube containing prewarmed PBS and 1 mM DTT and shaken for 10 minutes at 0.006158 g and 37°C and then washed with PBS. The tissue was removed and incubated in HBSS supplemented with 1.5 mM EDTA for 15 minutes at 0.006158 g and 37°C. Tubes containing the tissue were vortexed for 1 minute, and tissue was removed. Intestinal epithelial cells were centrifuged down to a pellet and resuspended in 1 mL PBS. Cells were then filtered and either stained for flow cytometry or used for the lysozyme activity assay.
Transfection of HEK293T cells. HEK293T cells were transfected with either an empty MSCV-P2GM plasmid or MSCV-P2GM mDEL plasmid. 3 μg plasmid was added to 18 μl PEI and 172 μl DMEM and mixed gently. Plasmid was incubated at room temperature for 20 minutes before the addition of 2 mL complete DMEM (10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin). HE293T cells were incubated in plasmid for 2 days. Additional complete DMEM was added after overnight incubation, and whole media were changed 2 days after transfection. Cells were analyzed by flow cytometry on the third day to check transfection efficiency.
Lysozyme activity assay. To analyze lysozyme activity, the EnzChek Lysozyme Assay Kit (Molecular Probes) was used according to manufacturer's instructions, with modifications for testing on cells. Transfected HEK293T cells, isolated IECs, and whole intestine sections were used for the assay. 5 × 10 4 mDEL-expressing cells or 8-mm sections of the small intestine of Villin cre+ mDEL loxp mice were used. Fluorescence was measured using a fluorescence microplate reader with a fluorescein filter.
gDNA extraction. gDNA was extracted from fecal pellets collected from mice using a Qiagen QIAamp Fast DNA Stool Mini Kit according to manufacturer's instructions with adjustments. Stool was collected into 2-mL microcentrifuge tubes (Eppendorf). 1 mL InhibitEX buffer was added to each stool sample and vortexed until stool sample was homogenized. The suspension was heated to 95°C for 10-15 minutes and vortexed for 15 seconds. The sample was centrifuged for 1 minute, and 600 μl supernatant was added to 25 μl Proteinase K (Roche). 600 μl Buffer AL was added to the sample and vortexed for 15 seconds before it was incubated at 70°C for 10 minutes. 600 μl ethanol was added to the lysate and mixed by vortexing. Lysate was added to the QIAamp spin column and centrifuged for 1 minute. Filtrate was discarded. Once all sample has been loaded onto column, 500 μl buffer AW1 (Qiagen QIAamp Fast DNA Stool Mini Kit) was added to the column and centrifuged for 1 minute. The column was then washed with 500 μl buffer AW2 (Qiagen QIAamp Fast DNA Stool Mini Kit) and centrifuged for 3 minutes. Column was centrifuged for 3 minutes and allowed to dry for 5 minutes at room temperature. To elute gDNA, 200 μl buffer ATE (Qiagen QIAamp Fast DNA Stool Mini Kit) was added to the column membrane and incubated for 2 minutes at room temperature before elution by centrifugation for 1 minute. Samples were stored at -20 o C. RNA sequencing. HEL-specific cells and non-HEL-specific cells were FAC sorted in TRIzol Reagent (Invitrogen) from spleens, mLNs, and PPs of Villin cre+ mDEL loxp SW HEL and RVillin cre+ mDELloxp(BCL2) mice (100,000 cells in 500 μl TRIzol). RNA was isolated by the manufacturer's instruction. Purified RNA was further passed through the Qiagen RNA isolation kit column to remove any remaining residual. cDNA was synthesize using SMART (Switching Mechanism at 5′ End of RNA template) technology, and RNA sequencing was performed at genomics core of La Jolla Institute of Allergy and Immunology, La Jolla, California, USA. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (accession GSE133159).
Statistics. All the graphs were generated using ELISA data. Flow and RT-PCR data were analyzed with Microsoft Office Excel and Prism 6. All the statistical analysis were done by unpaired 1-tailed Student's t test or 2-way ANOVA for analyzing multiple groups. All the experiments were performed at least 3 times, unless specified otherwise in the figure legends.
Study approval. All animals were treated in accordance with the ethical standards set approved by Sanford Burnham Prebys Medical Discovery's Institutional Animal Care and Use Committee.
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